Home | Welcome to Contract Pharma   
Last Updated Thursday, July 10 2014
Print

Search Results for 'Phase II'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

By Gil Roth
Published November 11, 2013
Chronic pain treatment Z160 cancelled, company to focus on Z944 Read More »
By Gil Roth
Published November 5, 2013
Zerenex trial reaches goals in NDD-CKD patients Read More »
By Gil Roth
Published October 11, 2013
Trial showed no PML cases Read More »
By Gil Roth
Published October 9, 2013
IPT trials in patients with wet AMD and VMT Read More »
Published September 24, 2012
Contractor error associated with bavituximab trial Read More »
Published May 25, 2011
Sixth milestone resulting from 2005 CNS pact Read More »
Published April 15, 2011
Galapagos NV will discontinue its Phase II trial for GLPG0259 in rheumatoid arthritis (RA) following a planned interim analysis that did not support continuing development of the drug for RA. Read More »
Published March 15, 2010
Portola Pharmaceuticals and Merck achieved positive results from EXPLORE-Xa, a Phase II dose finding study of investigational oral direct Factor Xa inhibitor betrixaban. Read More »
By Kristin Brooks
Published January 29, 2014
To conduct Phase II trial of NurOwn in ALS Read More »
By Kristin Brooks
Published December 13, 2013
Stellar to provide GMP grade KLH for OBI-822 immunotherapy Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On